SBI a buy on dips; big move over in pharma: Nischal Maheshwari
As we are going back to normalcy, the easy money has already been made in pharma and it is going to be very stock specific, says Nischal Maheshwari, CEO, Centrum Broking.What will be the impact on Vodafone after Mr Birlas resignation? Also, how exactly…
